Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02693145 · ClinicalTrials.gov registry record · NA
Cooperative Re-Engagement Controlled Trial (CoRECT)
A NA study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- NA
- Development phase
- 1,893
- Enrollment target
NCT02693145: Completed NA study, sponsored by Centers for Disease Control and Prevention.
NCT02693145 is a NA study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 1,893 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (35% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02693145, a NA study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,893 participants
- Enrollment target
Study Summary
CoRECT will help identify the important components of a data-sharing partnership between health departments and HIV care providers, and determine the extent to which a health department intervention can increase the number of HIV-infected persons out-of-care who: (a) link to an HIV clinic; (b) remain in HIV medical care; (c) achieve HIV viral load suppression within 12 months; and (d) achieve durable HIV viral load suppression over 18 months. We will also measure the cost-effectiveness of this intervention in regards to improved health in the individuals (re)-engaged in HIV care and reductions in further HIV transmission in the community.
Primary Outcome
Patient will attend one clinical visit at CoRECT clinic to receive HIV medical care
Interventions
- OTHER Anti-Retroviral Treatment and Access to Services (ARTAS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,893 participants |
| Start Date | 2016-08 |
| Est. Completion | 2020-08 |
| Phase | NA |
What the finished NCT02693145 record still lists
NCT02693145 is an interventional study that assigns participants to a tested intervention. Its 1,893 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (35% higher).
The record links to 0 conditions, and to 1 intervention - of which Anti-Retroviral Treatment and Access to Services (ARTAS) is the first listed.
NCT02693145 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02693145 about?
NCT02693145 is a clinical study titled "Cooperative Re-Engagement Controlled Trial (CoRECT)". CoRECT will help identify the important components of a data-sharing partnership between health departments and HIV care providers, and determine the extent to which a health department intervention can increase the number of HIV-infected persons out-of-care who: (a) link to an HIV clinic; (b) remai...
What is the current status of trial NCT02693145?
This trial is currently completed. It is a NA study. The enrollment target is 1,893 participants. The study started on 2016-08. Estimated completion is 2020-08.
What interventions are being tested in trial NCT02693145?
The interventions under investigation include: Anti-Retroviral Treatment and Access to Services (ARTAS) (OTHER).
Who is sponsoring clinical trial NCT02693145?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02693145's enrollment target sits among peer trials
1,893 55th of 2000 higher than 1,946 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07308717 · 1,896 participants · Phase 4
Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol
- NCT03729180 · 1,900 participants · NA
The ImPreSS Trial: Pharmacogenomic Decision Making at Time of Surgery
- NCT05712200 · 1,900 participants · Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- NCT06929806 · 1,900 participants · Phase 3
Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia